Sandra Donnelly
- Co-authors
- John M. KirkwoodSanjiv S. AgarwalaJanice Shipe-SpotloeAhmad A. TarhiniCatherine BenderHoward EdingtonDorothea BeckerDaniel L. Farkas
- Topics
- Melanoma and MAPK Pathways (4 papers)CAR-T cell therapy research (2 papers)Cutaneous Melanoma Detection and Management (2 papers)
- Partner nations
- United States
In The Last Decade
Sandra Donnelly
8 papers receiving 347 citations
Peers
Comparison fields: 5 of 61
- Oncology 196
- Immunology 142
- Molecular Biology 122
- Pathology and Forensic Medicine 31
- Cancer Research 29
Countries citing papers authored by Sandra Donnelly
This map shows the geographic impact of Sandra Donnelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Donnelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Donnelly more than expected).
Fields of papers citing papers by Sandra Donnelly
This network shows the impact of papers produced by Sandra Donnelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Donnelly. The network helps show where Sandra Donnelly may publish in the future.
Co-authorship network of co-authors of Sandra Donnelly
This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Donnelly. A scholar is included among the top collaborators of Sandra Donnelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Donnelly. Sandra Donnelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 145 | |
| 2 | Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs. | 49 |
| 3 | Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions. | 40 |
| 4 | 38 | |
| 5 | Patient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanoma. | 20 |
| 6 | 16 | |
| 7 | Carmustine and streptozocin in refractory melanoma: an attempt at modulation of O-alkylguanine-DNA-alkyltransferase. | 31 |
| 8 | Molecular analysis of melanoma precursor lesions. | 21 |
About Sandra Donnelly
Sandra Donnelly is a scholar working on Pharmacology, Oncology and Immunology and Allergy, having authored 8 papers that have together received 360 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), CAR-T cell therapy research (2 papers) and Cutaneous Melanoma Detection and Management (2 papers). The work is most often cited by research in Biological Psychiatry (18 citations), Oncology (196 citations) and Immunology (142 citations). Sandra Donnelly has collaborated with scholars based in United States. Frequent co-authors include John M. Kirkwood, Sanjiv S. Agarwala, Janice Shipe-Spotloe, Ahmad A. Tarhini, Catherine Bender, Howard Edington, Dorothea Becker, Daniel L. Farkas, Kevin F. Dyer and David J. Tweardy. Their work appears in journals such as Journal of Clinical Oncology, Cancer Immunology Immunotherapy and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.